Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Changes in Stockholders??? Equity

v3.26.1
Consolidated Statements of Changes in Stockholders’ Equity - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Balance at Dec. 31, 2023 $ 104 $ 58,721,538 $ (4,652) $ (35,318,538) $ 23,398,452
Balance (in Shares) at Dec. 31, 2023 1,041,582        
-restricted stock units 117,460 117,460
-restricted stock units (in Shares) 4,168        
-stock options 648,367 648,367
-warrants 7,866 7,866
Proceeds from September 2024 offering of pre-funded and common warrants, net 4,517,285 4,517,285
Issuance of common stock from the exercise of pre-funded warrants, net $ 35 314 349
Issuance of common stock from the exercise of pre-funded warrants, net (in Shares) 348,513        
Deemed dividend - warrant modification 359,656 (359,656)
Foreign currency translation (2,519) (2,519)
Net loss (13,904,584) (13,904,584)
Balance at Dec. 31, 2024 $ 139 64,372,486 (7,171) (49,582,778) 14,782,676
Balance (in Shares) at Dec. 31, 2024 1,394,263        
-stock options 295,894 295,894
Issuance of common stock under ATM agreement, net $ 80 2,078,268 2,078,348
Issuance of common stock under ATM agreement, net (in Shares) 801,278        
Realized foreign currency translation loss from dissolution of subsidiaries 7,171 7,171
Proceeds from May 2025 public offering of common stock, pre-funded warrants and warrants, net $ 357 4,214,149 4,214,506
Proceeds from May 2025 public offering of common stock, pre-funded warrants and warrants, net (in Shares) 3,571,428        
Proceeds from December 2025 public offering of common stock and pre-funded warrants, net $ 1,485 51,996,631 51,998,116
Proceeds from December 2025 public offering of common stock and pre-funded warrants, net (in Shares) 14,846,665        
Issuance of common stock from the exercise of warrants, net $ 161 2,248,839 2,249,000
Issuance of common stock from the exercise of warrants, net (in Shares) 1,606,428        
-warrants 1,573 1,573
Issuance of common stock from the exercise of pre-funded warrants, net $ 87 784 871
Issuance of common stock from the exercise of pre-funded warrants, net (in Shares) 871,000        
Foreign currency translation 18,766 18,766
Net loss (20,427,683) (20,427,683)
Balance at Dec. 31, 2025 $ 2,309 $ 125,208,624 $ 18,766 $ (70,010,461) $ 55,219,238
Balance (in Shares) at Dec. 31, 2025 23,091,062